Cleared Traditional

K080849 - MICROSHEATH LP AND LP-AT

K080849 is an FDA 510(k) clearance for MICROSHEATH LP AND LP-AT, manufactured by Flowcardia, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K080849 · Flowcardia, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2008
Decision
121d
Days
Class 2
Risk

K080849 is an FDA 510(k) clearance for the MICROSHEATH LP AND LP-AT. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Flowcardia, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on July 25, 2008 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Flowcardia, Inc. devices

FDA 510(k) Submission Details - K080849

510(k) Number K080849 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 2008
Decision Date July 25, 2008
Days to Decision 121 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 125d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 669
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K080849.
GORE TRI-LOBE BALLOON CATHETER
K081799 · W.L. Gore & Associates, Inc. · Oct 2008
6F PROXIS SYSTEM
K073700 · St. Jude Medical, Inc. · Oct 2008
MINI GHOST, MODEL: 507
K082524 · NuMED, Inc. · Sep 2008
MODIFIED HD GUIDE CATHETER
K080583 · Concentric Medical, Inc. · Jul 2008
NUCLEUS-X, MODEL 230X
K081680 · NuMED, Inc. · Jul 2008
SCOUTPRO CS LEAD INTRODUCER SYSTEM
K080988 · Biotronik, Inc. · May 2008